PLCG1 and B-cell chronic lymphocytic leukemia: In addition to the above pharmacological approach, we assessed the role of PLCγ1 in PKHB1-mediated PCD in primary CLL cells using lentiviral down-regulation of PLCG1 with two independent shRNAs.